(Total Views: 153)
Posted On: 09/27/2019 1:42:29 PM
Post# of 44523
$MDCL The cannabis space is targeting some relatively remarkable growth estimates, with analysts routinely jacking up forecasts. But two dynamics have made it increasingly difficult for investors in the space: the increasing supply along with demand to suit the process of legislative and mainstream adoption has pressured cannabis pricing, and the enthusiasm of investors along the way has created some valuation issues that have led to significant pain for poorly timed entries.
That leaves us with a classic stockpicker’s market in the pot stock space. We review several candidates to aid in your analysis: Tilray Inc (NASDAQ:TLRY), Medicine Man Technologies Inc (OTCMKTS:MDCL), and OrganiGram Holdings Inc (NASDAQ:OGI).
Medicine Man Technologies Inc (OTCMKTS:MDCL) generated sales of $1.8M, according to information released in the company’s most recent quarterly financial report. In addition, the company is sitting on about $4.3M in cash. That puts the stock in a sweet spot as far as valuation in the pot space, with shares trading at around 14x sales.
That sense has fueled aggressive interest in the name, with shares rallying as much as 30% higher so far during September alone.
As we have noted in the past, the company is capitalizing on recent changes in Colorado state law (namely, passage of HB 19-1090, which will take effect on November 1, and allow for outside investors, venture capitalists and private equity firms to gain investment access to Colorado’s cannabis industry.
MDCL has been a well-respected and successful advisor and consultant to firms in the cannabis industry for many years. But this shift in the legal context has created a new opportunity to consolidate production and distribution under the MDCL umbrella in a roll-up that could produce significant revenue growth for a stock that is already cheap relative to peers in the space. https://www.journaltranscript.com/2019/09/com...-mdcl-ogi/
That leaves us with a classic stockpicker’s market in the pot stock space. We review several candidates to aid in your analysis: Tilray Inc (NASDAQ:TLRY), Medicine Man Technologies Inc (OTCMKTS:MDCL), and OrganiGram Holdings Inc (NASDAQ:OGI).
Medicine Man Technologies Inc (OTCMKTS:MDCL) generated sales of $1.8M, according to information released in the company’s most recent quarterly financial report. In addition, the company is sitting on about $4.3M in cash. That puts the stock in a sweet spot as far as valuation in the pot space, with shares trading at around 14x sales.
That sense has fueled aggressive interest in the name, with shares rallying as much as 30% higher so far during September alone.
As we have noted in the past, the company is capitalizing on recent changes in Colorado state law (namely, passage of HB 19-1090, which will take effect on November 1, and allow for outside investors, venture capitalists and private equity firms to gain investment access to Colorado’s cannabis industry.
MDCL has been a well-respected and successful advisor and consultant to firms in the cannabis industry for many years. But this shift in the legal context has created a new opportunity to consolidate production and distribution under the MDCL umbrella in a roll-up that could produce significant revenue growth for a stock that is already cheap relative to peers in the space. https://www.journaltranscript.com/2019/09/com...-mdcl-ogi/
(0)
(0)
